Clinical Laboratory Services

Clinical research solutions for pharma, biotech and CROs.

  • Services
  • Overview
See all services
Contact a scientist

Services

Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.We offer a comprehensive range of services comprising the identification, development, validation, analysis and interpretation of biomarker and bioanalytical readouts in translational and clinical research. Our global network of labs serve pharma and biotech customers directly or through a CRO, adhering to GCP/GLP/GMP guidelines.

SO 1

Biomarkers

The scientists at Synexa Life Sciences develop optimum biomarker strategies for biomarker discovery, selection, and analysis that meet your clinical development goals. Our global setup supports research programs from translational research through to late-stage clinical trials and post-marketing surveillance. We focus on the careful selection of markers to ensure results that support decision-making and progression through the therapeutic pipeline.

SO 2

Clinical Bioanalysis

Synexa Labs specialise in the development, validation, and delivery of a wide range of complex and custom-designed assays.

We strive to be at the forefront of scientific innovation, housing the tools and expertise required to deliver accurate, reliable, and streamlined bioanalytical solutions for even the most complex programs.

SO 3

Radiopharmaceutical Bioanalysis

Our facility in Turku, Finland offers a full series of radiobiological services that advance customers’ radiopharmaceutical drug development.

Our radiobiological services follow strict regulatory standards for safety and efficacy, delivered by a team that is licensed and experienced in handling a variety of key isotopes including Ac-225, Th-227, H-3, I-125, and I-131.

SO 4

Translational

Our translational services help to assess candidate therapeutics and generate clinically relevant data using fresh human samples from both healthy and diseased populations.

Translational studies assess candidate drugs in clinically relevant samples from a broad range of therapeutic indications, delivering critical insights including the safety profile, efficacy, and mechanism of action, providing the assurance needed to confidently progress into clinical trials.

SO 5

Flow Cytometry

At Synexa we create robust, bespoke flow cytometry panels, custom-designed to meet customer-specific needs and requirements.

Our global lab capabilities offer a comprehensive suite of advanced assays, including immunophenotyping assays, target engagement PK/PD assays, as well as an array of functional assays.

SO 6

Proteomics

At Synexa Life Sciences, we are excited to introduce the latest addition to our technology portfolio – Olink Target Platform.

Offering unparalleled precision and sensitivity, Olink Target propels your protein biomarker discovery research forward. From just a single, low-volume sample, we analyse up to 92 protein biomarkers, providing you with the information required to advance your therapeutic research.

SO 7

Tissue Imaging

Leveraging advanced technologies, we provide comprehensive and precise insights into spatial relationships in cells and tissues.

Our services empower researchers to gain a deeper understanding of tissue microenvironments and cellular behaviours, allowing for the precise understanding of therapeutic drug monitoring and efficacy.

SO 8

Genomics

Synexa’s dedicated genomics research team specialises in developing bespoke, precise, and robust assays that propel clinical research forward.

Our experienced team is well-versed in solving researchers’ most complex challenges, including those around single nucleotide polymorphism detection and quantification, larger-scale marker screening, targeted gene sequencing, as well as quantitative polymerase chain reaction (qPCR).

SO 9

Biomarker Consulting

Our scientific team helps de-risk your development by providing support around key biomarker and bioanalytical considerations.

Selecting the correct targets and biomarkers which demonstrate clear biological effects are essential during early candidate development. Even when entering the clinic, downstream sample processing, assay development and analysis remain key to the ultimate success of the trial.

SO 10

ELISpot Assay Services

ELISpot (Enzyme-Linked ImmunoSpot) assays enable precise detection and quantification of antigen-specific immune responses at a single-cell level.

ELISpot is a highly sensitive assay that measures the secretion of cytokines, antibodies, or other immune markers, providing valuable insights into immune cell activity and function. They are essential for assessing immune responses in various disease settings, making them a powerful tool for immune monitoring and research.

Your Trusted Partner in Scientific Excellence

Synexa Group is dedicated to delivering innovative and reliable scientific solutions.
Let's get started

Therapeutic Expertise and Research Phase Expertise

We have experience in multiple therapeutic areas and continue to expand our knowledge base. Synexa’s global setup aims to support partners from preclinical translational research and biomarker developmentthrough to clinical bioanalysis of established and novel drug modalities.

A scientist looking into a microscope and adjusting its scope.

Discuss Real Solutions to Develop Your Therapeutic Pipeline

Bridging the gap between science and life.

Let's get started